Skip to content
10-Q

Quarterly Report

CHINA PHARMA HOLDINGS, INC. CPHI

0001213900-25-043334

← back to feed
Filed
May 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 14, 2025 3.26M sh
Short Term Debt Q1 2025 · Mar 31, 2025 $1.15M
Short Term Debt Q1 2025 · Dec 31, 2024 $1.14M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $400K
Current Liabilities Q1 2025 · Mar 31, 2025 $5.12M
Current Liabilities Q1 2025 · Dec 31, 2024 $5.02M
Total Liabilities Q1 2025 · Mar 31, 2025 $7.25M
Total Liabilities Q1 2025 · Dec 31, 2024 $7.14M
Current Assets Q1 2025 · Mar 31, 2025 $2.85M
Current Assets Q1 2025 · Dec 31, 2024 $3.27M
Total Assets Q1 2025 · Mar 31, 2025 $14.22M
Total Assets Q1 2025 · Dec 31, 2024 $14.89M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$585.16K
Stockholders Equity Q1 2025 · Mar 31, 2024 $8.29M
Stockholders Equity Q1 2025 · Dec 31, 2023 $7.45M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.72
Eps Basic Q1 2025 · Mar 31, 2024 −$0.72
Sga Expense Q1 2025 · Mar 31, 2024 $488.46K
Rd Expense Q1 2025 · Mar 31, 2024 $31.45K
Net Income Q1 2025 · Mar 31, 2024 −$955.89K
Operating Income Q1 2025 · Mar 31, 2024 −$916.05K
Gross Profit Q1 2025 · Mar 31, 2024 −$290.02K
Cost Of Revenue Q1 2025 · Mar 31, 2024 $1.66M
Revenue Q1 2025 · Mar 31, 2024 $1.37M